المؤلفون: McCrimmon, Rory J.¹ (AUTHOR), Falla, Edel² (AUTHOR), Sha, Jo Zhou² (AUTHOR), Alsaleh, Abdul Jabbar Omar³ (AUTHOR), Lew, Elisheva⁴ (AUTHOR) Elisheva.Lew@sanofi.com, Hudson, Richard⁵ (AUTHOR), Baxter, Mike⁵ (AUTHOR), Palmer, Karen⁵ (AUTHOR)

المصدر: Diabetes Therapy. Dec2021, Vol. 12 Issue 12, p3217-3230. 14p.

مصطلحات موضوعية: *TYPE 2 diabetes, *GLUCAGON-like peptide-1 receptor, *INSULIN, *GLYCEMIC control, *GLUCAGON-like peptide-1 agonists

مصطلحات جغرافية: UNITED Kingdom

المؤلفون: Tack, Cees J.¹ (AUTHOR) cees.tack@radboudumc.nl, Jacob, Stephan² (AUTHOR), Desouza, Cyrus³ (AUTHOR), Bain, Stephen C.⁴ (AUTHOR), Buse, John B.⁵ (AUTHOR), Nauck, Michael A.⁶ (AUTHOR), Petrie, John R.⁷ (AUTHOR), Poulter, Neil R.⁸ (AUTHOR), Pratley, Richard E.⁹ (AUTHOR), Stegmann, Helen Vanya B. K.¹⁰ (AUTHOR), Bosch‐Traberg, Heidrun¹⁰ (AUTHOR), Startseva, Elena¹⁰ (AUTHOR), Zinman, Bernard¹¹ (AUTHOR)

المصدر: Diabetes, Obesity & Metabolism. Nov2019, Vol. 21 Issue 11, p2450-2458. 9p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *INSULIN, *MEDICATION safety, *GLUCAGON-like peptide-1 agonists, *SOMATOMEDIN C, *TYPE 2 diabetes

المؤلفون: Abreu, Marconi¹ (AUTHOR), Tumyan, Anna¹ (AUTHOR), Elhassan, Ahmed¹ (AUTHOR), Peicher, Katherine^1,2 (AUTHOR), Papacostea, Olivia^1,3 (AUTHOR), Dimachkie, Perihan^1,4 (AUTHOR), Siddiqui, Muhammad S.^1,5 (AUTHOR), Pop, Laurentiu M.¹ (AUTHOR), Gunasekaran, Uma^1,6 (AUTHOR), Meneghini, Luigi F.^1,6 (AUTHOR), Adams‐Huet, Beverley^1,7 (AUTHOR), Li, Xilong⁷ (AUTHOR), Lingvay, Ildiko^1,7 (AUTHOR) ildiko.lingvay@utsouthwestern.edu

المصدر: Diabetes, Obesity & Metabolism. Sep2019, Vol. 21 Issue 9, p2133-2141. 9p.

مصطلحات موضوعية: *INSULIN aspart, *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *INSULIN, *REGULATION of body weight

العنوان البديل: LIRAGLUTID I INSULIN DETEMIR U KOMBINACIJI - NOVI TERAPIJSKI IZBOR KOD OSOBA SA DIJABETESOM TIP 2: PRIKAZ SLUČAJA.

المؤلفون: Velojić-Golubović, Milena^1,2 milenavg@yahoo.com

المصدر: Acta Medica Medianae. Dec2017, Vol. 56 Issue 4, p132-137. 6p.

مصطلحات موضوعية: *TREATMENT of diabetes, *GLUCAGON-like peptide-1 receptor, *INSULIN

المؤلفون: Mehta, Roopa, Billings, Liana K., Liebl, Andreas, Vilsbøll, Tina

المصدر: Mehta , R , Billings , L K , Liebl , A & Vilsbøll , T 2022 , ' Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes ' , Diabetic Medicine , vol. 39 , no. 9 , e14901 . https://doi.org/10.1111/dme.14901Test

مصطلحات موضوعية: diabetes mellitus type 2, glucagon-like peptide-1 receptor, IDegLira, insulin, liraglutide, lixisenatide, treatment outcomes

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/dme.14901Test
https://curis.ku.dk/portal/da/publications/transitioning-from-basalbolus-or-premixTest-insulin-therapy-to-a-combination-of-basal-insulin-and-glucagonlike-peptide1-receptor-agonist-in-people-with-type-2-diabetes(df251d3b-c872-4250-bb1a-5f55c609c569).html
https://curis.ku.dk/ws/files/321833797/Diabetic_Medicine_2022_Mehta_Transitioning_from_basal_bolus_or_premix_insulin_therapy_to_a_combination_of_basal.pdfTest

المؤلفون: Yin, Jianhong, Han, Minmin, Li, Linhui, Li, Yang, Liu, Zi'ang, Yang, Jing, Liu, Yunfeng

المصدر: Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy; Oct2021, Vol. 14, p4399-4407, 9p

مصطلحات موضوعية: INSULIN, TYPE 2 diabetes, DESMOPRESSIN, GLUCAGON-like peptide-1 receptor, LIRAGLUTIDE, BLOOD sugar, INSULIN resistance, GLYCOSYLATED hemoglobin

المؤلفون: Kim, Sun H., Abbasi, Fahim, Nachmanoff, Clara, Stefanakis, Konstantinos, Kumar, Ajay, Kalra, Bhanu, Savjani, Gopal, Mantzoros, Christos S.

المصدر: Diabetes, Obesity & Metabolism; Feb2021, Vol. 23 Issue 2, p489-498, 10p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, LIRAGLUTIDE, RANDOMIZED controlled trials, BODY weight, BLOOD sugar, GLUCAGON-like peptide-1 receptor, BODY mass index, INSULIN

المؤلفون: Rayner, Christopher K., Wu, Tongzhi, Aroda, Vanita R., Whittington, Craig, Kanters, Steve, Guyot, Patricia, Shaunik, Alka, Horowitz, Michael

المصدر: Diabetes, Obesity & Metabolism; Jan2021, Vol. 23 Issue 1, p136-146, 11p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, INSULIN, LIRAGLUTIDE, EXENATIDE

المؤلفون: Brianna, Evans, Brooke, Stoltzfus, Nikhil, Acharya, Jennifer E, Nyland, Amy C, Arnold, Christopher S, Freet, Scott C, Bunce, Patricia S, Grigson

المصدر: Brain Research Bulletin. 189:163-173

مصطلحات موضوعية: General Neuroscience, Liraglutide, Glucagon-Like Peptide-1 Receptor, Rats, Heroin, Glucose, Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Recurrence, Animals, Humans, Hypoglycemic Agents, Insulin, Cues

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e28ede3cd73658364987b03155c0f4Test
https://doi.org/10.1016/j.brainresbull.2022.08.022Test

المؤلفون: Weston, C¹, Poyner, D², Patel, V³, Dowell, S⁴, Ladds, G¹

المصدر: British Journal of Pharmacology. Aug2014, Vol. 171 Issue 15, p3651-3665. 15p. 5 Charts, 7 Graphs.

مصطلحات موضوعية: *G proteins, *GLUCAGON-like peptide-1 receptor, *YEAST, *GLYCEMIC index, *INSULIN, *TYPE 2 diabetes treatment, *TARGETED drug delivery